China Resources Double-Crane Pharmaceutical Co.,Ltd.

SHSE:600062 Stock Report

Market Cap: CN¥21.4b

China Resources Double-Crane PharmaceuticalLtd Dividends and Buybacks

Dividend criteria checks 3/6

China Resources Double-Crane PharmaceuticalLtd is a dividend paying company with a current yield of 0.96% that is well covered by earnings.

Key information

1.0%

Dividend yield

0.005%

Buyback Yield

Total Shareholder Yield1.0%
Future Dividend Yield1.7%
Dividend Growth11.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.200
Payout ratio27%

Recent dividend and buyback updates

Recent updates

The China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 29
The China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) First-Quarter Results Are Out And Analysts Have Published New Forecasts

China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Low P/E No Reason For Excitement

Oct 21
China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Low P/E No Reason For Excitement

An Intrinsic Calculation For China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Suggests It's 49% Undervalued

Sep 30
An Intrinsic Calculation For China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Suggests It's 49% Undervalued

We Think China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt With Ease

Jul 16
We Think China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt With Ease

China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 24
China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Just Reported And Analysts Have Been Lifting Their Price Targets

Investors Don't See Light At End Of China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Tunnel

Mar 02
Investors Don't See Light At End Of China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Tunnel

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 600062's dividend payments have been volatile in the past 10 years.

Growing Dividend: 600062's dividend payments have fallen over the past 10 years.


Dividend Yield vs Market

China Resources Double-Crane PharmaceuticalLtd Dividend Yield vs Market
How does 600062 dividend yield compare to the market?
SegmentDividend Yield
Company (600062)1.0%
Market Bottom 25% (CN)0.6%
Market Top 25% (CN)2.2%
Industry Average (Pharmaceuticals)1.7%
Analyst forecast (600062) (up to 3 years)1.7%

Notable Dividend: 600062's dividend (0.96%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).

High Dividend: 600062's dividend (0.96%) is low compared to the top 25% of dividend payers in the CN market (2.17%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (27.2%), 600062's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (19%), 600062's dividend payments are well covered by cash flows.


Discover strong dividend paying companies